University of Worcester Worcester Research and Publications
 
  USER PANEL:
  ABOUT THE COLLECTION:
  CONTACT DETAILS:

Bleeding Risk of Transbronchial Cryobiopsy Compared to Transbronchial Forceps Biopsy in Interstitial Lung Disease - a Prospective, Randomized, Multicentre Cross-over Trial

Hetzel, J., Eberhardt, R., Petermann, C., Gesierich, W., Darwiche, K., Hagmeyer, L., Muche, R., Kreuter, M., Lewis, Richard, Ehab, A., Boeckeler, M. and Haentschel, M. (2019) Bleeding Risk of Transbronchial Cryobiopsy Compared to Transbronchial Forceps Biopsy in Interstitial Lung Disease - a Prospective, Randomized, Multicentre Cross-over Trial. Respiratory Research, 20 (1). Article no. 140. ISSN 1465-993X

[img]
Preview
Text
Bleeding risk of transbronchial cryobiopsy Hetzel et al.pdf
Available under License Creative Commons Attribution.

Download (704kB) | Preview

Abstract

Bronchoscopic cryobiopsy is a new method of bronchoscopic tissue sampling in interstitial lung disease. In case of transbronchial biopsies, the resultant tissue samples are of high quality, and the lung parenchyma seen in the samples is adequate for a histological diagnosis in most cases. Bleeding after transbronchial biopsy is the most important procedure- associated complication and may be life threatening. This study addresses the risk of bleeding of transbronchial cryobiopsy. In this prospective, randomized, controlled multicentre study 359 patients with interstitial lung disease requiring diagnostic bronchoscopic tissue sampling were included. Both conventional transbronchial forceps biopsy and transbronchial cryobiopsy were undertaken in each patient. The sequence of the procedures was randomized. Bleeding severity was evaluated semi-quantitatively as "no bleeding", "mild" (suction alone), "moderate" (additional intervention) or "severe" (prolonged monitoring necessary or fatal outcome), for each intervention. In 359 patients atotal of 1160 cryobiopsies and 1302 forceps biopsies were performed. Bleeding was observed after forceps biopsy in 173 patients (48.2%) and after cryobiopsy in 261 patients (72.7%). Bleeding was significantly greater in the cryobiopsy group (cryobiopsy/forceps biopsy: no bleeding 27.3%/51.8%; mild 56.5%/44.0%; moderate 15.0%/4.2%; severe 1.2%/0%; p < 0.001). The rate of clinically relevant bleeding (moderate or severe) was higher after the cryobiopsy procedures compared to the forceps biopsies (16.2% vs. 4.2%, p < 0.05). No fatal bleeding complications occurred. Compared to transbronchial forceps biopsy, transbronchial cryobiopsy was associated with an increased risk of bleeding which is of clinical relevance. Therefore training and additional precautions for bleeding control should be considered. The study was registered with clinicaltrials.gov ( NCT01894113 ).

Item Type: Article
Additional Information:

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

The full-text of the online published article can be accessed via the official URL.

Uncontrolled Keywords: bleeding risk, cryobiopsy, forceps biopsy, interstitial lung disease, randomized prospective multicenter trial
Divisions: Academic Departments > Institute of Science and the Environment
Related URLs:
Copyright Info: Open Access article
SWORD Depositor: Prof. Pub Router
Depositing User: Tanya Buchanan
Date Deposited: 30 Jul 2019 08:37
Last Modified: 30 Jul 2019 08:37
URI: https://eprints.worc.ac.uk/id/eprint/8386

Actions (login required)

View Item View Item
 
     
Worcester Research and Publications is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.